Literature DB >> 2432180

Two monoclonal antibodies recognize Alzheimer's neurofibrillary tangles, neurofilament, and microtubule-associated proteins.

H Ksiezak-Reding, S H Yen.   

Abstract

Two monoclonal antibodies that recognize Alzheimer's neurofibrillary tangles (ANTs), AD10 and AB18, have been characterized by immunoblotting against human and calf spinal cord neurofilament (NF) and calf brain microtubule preparations. Both antibodies bind to the 200-kilodalton (kd) (NF-H) and 160-kd (NF-M) but not to the 68-kd (NF-L) NF triplet proteins. They also bind to high-molecular-weight microtubule-associated proteins (MAPs) and tau. AD10 immunostains MAP2 and MAP1 families, whereas AB18 stains mainly MAP1 bands. Preincubation of intact filament preparation or nitrocellulose strips containing electroblotted NF proteins with Escherichia coli alkaline phosphatase completely blocks AD10 binding and partially blocks binding of AB18. These results suggest that the determinants recognized by these antibodies are phosphorylated. Immunoblotting of peptide fragments generated by limited proteolysis of NF proteins with alpha-chymotrypsin and Staphylococcus aureus V8 protease shows that the localization of the antigenic determinants to AD10 and AB18 in NF-H is approximately 100 and 60 kd, respectively, away from the carboxy terminal, a region previously shown to form the NF projection side arm. In NF-M, the antigenic determinants to both antibodies are located also in the projection side arm, in a 60-kd polypeptide adjacent to the alpha-helical filament core. The results show that ANTs contain at least two phosphorylated antigenic sites that are present in NF and MAPs, a finding suggesting that ANTs may be composed of proteins or their fragments with epitopes shared by cytoskeletal proteins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2432180     DOI: 10.1111/j.1471-4159.1987.tb04114.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Filaments of Lewy bodies contain insoluble cytoskeletal elements.

Authors:  P G Galloway; P Mulvihill; G Perry
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

2.  Isolation of a major protein component of Rosenthal fibers.

Authors:  J E Goldman; E Corbin
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

3.  A monoclonal antibody that recognizes a phosphorylated epitope in Alzheimer neurofibrillary tangles, neurofilaments and tau proteins immunostains granulovacuolar degeneration.

Authors:  D W Dickson; H Ksiezak-Reding; P Davies; S H Yen
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

4.  Aberrant GAP-43 gene expression in Alzheimer's disease.

Authors:  S M de la Monte; S C Ng; D W Hsu
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

Review 5.  Probing modifications of the neuronal cytoskeleton.

Authors:  L C Doering
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

6.  Immunochemical demonstration of tropomyosin in the neurofibrillary pathology of Alzheimer's disease.

Authors:  P G Galloway; P Mulvihill; S Siedlak; M Mijares; M Kawai; H Padget; R Kim; G Perry
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

7.  Relative abundance of tau and neurofilament epitopes in hippocampal neurofibrillary tangles.

Authors:  M L Schmidt; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

8.  Acrylamide alters neurofilament protein gene expression in rat brain.

Authors:  H Endo; S Kittur; M I Sabri
Journal:  Neurochem Res       Date:  1994-07       Impact factor: 3.996

9.  Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for beta-APP751.

Authors:  L S Higgins; J M Rodems; R Catalano; D Quon; B Cordell
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.